GLP-1 medications offer a scientifically-backed alternative, providing benefits such as: Sustained Weight Loss: Clinical studies have shown that GLP-1 therapies can lead to significant and sustainable weight loss
Among these, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) coagonists draw much attention because these agents showed potent weight lowering efficacy
The main shelf, toward the back where temperature is most stable
Company-reported Phase 3 topline results have circulated in 20252026, and a regulatory filing has been anticipated, but retatrutide is not FDA- or EMA-approved and is not available as a prescription product
Patients should expect to receive an injection at least once a week, though this number may change
HSA: only available with a high-deductible health plan FSA: opened through your employer, usually during open enrollment Get access to your account, debit card, or claim portal so youre ready for checkout or reimbursement